PSMA binding ligand-linker conjugates and methods for using
US10517957B2 · kind B2 · utility
17Cited by
126References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 4, 2018 |
| Grant date | Dec 31, 2019 |
| Priority date | — |
| Expiry date | Jun 4, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K5/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein are pharmaceutical composition containing them and methods of using the conjugates and compositions. Also described are processes for manufacture of the conjugates and the compositions containing them.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.